Teva Pharmaceutical (TEVA)
NYSE:TEVA

Teva Pharmaceutical Stock Forecast & Price Target

5,905 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Hold
6Ratings
2 Buy
1 Hold
3 Sell
Based on 6 analysts giving stock ratings to
Teva
Pharmaceutical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TEVA Stock Price Prediction

Average Price Target

$9.17
▲(2.57% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Teva Pharmaceutical in the last 3 months. The average price target is $9.17 with a high forecast of $11.00 and a low forecast of $7.00. The average price target represents a 2.57% change from the last price of $8.94.
Highest Price Target$11.00Average Price Target$9.17Lowest Price Target$7.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Evercore ISI
Hold
Reiterated
Analysts Offer Insights on Healthcare Companies: Incyte (NASDAQ: INCY) and Teva Pharmaceutical (NYSE: TEVA)
Argus Research
Hold
Downgraded
Teva downgraded to Hold from Buy at ArgusTeva downgraded to Hold from Buy at Argus
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

TEVA Financial Forecast

TEVA Earnings Forecast
Next quarter’s earnings estimate for TEVA is $0.71 with a range of $0.64 to $0.78. The previous quarter’s EPS was $0.59. TEVA beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.50% of the time in the same period. In the last calendar year TEVA has Outperformed its overall industry.
Next quarter’s earnings estimate for TEVA is $0.71 with a range of $0.64 to $0.78. The previous quarter’s EPS was $0.59. TEVA beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.50% of the time in the same period. In the last calendar year TEVA has Outperformed its overall industry.
TEVA Sales Forecast
Next quarter’s sales forecast for TEVA is $3.88B with a range of $3.67B to $4.01B. The previous quarter’s sales results were $3.56B. TEVA beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.95% of the time in the same period. In the last calendar year TEVA has Underperformed its overall industry.
Next quarter’s sales forecast for TEVA is $3.88B with a range of $3.67B to $4.01B. The previous quarter’s sales results were $3.56B. TEVA beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.95% of the time in the same period. In the last calendar year TEVA has Underperformed its overall industry.
TEVA Analyst Recommendation Trends
In the current month, TEVA has received 1 Buy ratings 1 Hold ratings, and 3 Sell ratings. The TEVA average analyst price target in the past 3 months is $9.17
In the current month, TEVA has received 1 Buy ratings 1 Hold ratings, and 3 Sell ratings. The TEVA average analyst price target in the past 3 months is $9.17

TEVA Stock Forecast FAQ

What is TEVA’s average 12-month price target, according to analysts?
Based on analyst ratings, Teva Pharmaceutical’s 12-month average price target is $9.17.
    What is TEVA’s upside potential, based on the analysts’ average price target?
    Teva Pharmaceutical has 2.57% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TEVA a Buy, Sell or Hold?
          Teva Pharmaceutical has a conensus rating of Hold which is based on 2 buy ratings, 1 hold ratings and 3 sell ratings.
            What is Teva Pharmaceutical’s price target?
            The average price target for Teva Pharmaceutical is $9.17. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $11.00 ,the lowest forecast is $7.00. The average price target represents 2.57% Increase from the current price of $8.94.
              What do analysts say about Teva Pharmaceutical?
              Teva Pharmaceutical’s analyst rating consensus is a ‘Hold. This is based on the ratings of 6 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis